Beacon Biosignals, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

Beacon Biosignals, Inc.
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Beacon Biosignals, Inc.. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Aug 25, 2026 to Aug 25, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code OLV appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 22 Boston Wharf Rd., 7th Floor, Unit 41, Boston, MA, 02210, US. Recorded on K261747, decision dated Aug 25, 2026.
Device categories in this collection
Standard Polysomnograph With Electroencephalograph.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
Report Studio
K261747 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.